ORAGENICS INC

Profile

Company Names

ORAGENICS INC

Addresses

4902 EISENHOWER BOULEVARD, SUITE 125, TAMPA, FL 33634

4902 EISENHOWER BLVD., SUITE 125, TAMPA, FL 33634

4902 EISENHOWER BOULEVARD, SUITE 125, TAMPA, FL 33634

3000 BAYPORT DRIVE, SUITE 685, TAMPA, FL 33607

13700 PROGRESS BLVD., ALACHUA, FL 32615

Phone Numbers

813-229-7600
813-286-7900
(813) 286-7900
386-418-4018

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

FLORIDA

Total Amount Raised:

$54,368,364.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2023-08-04 
$850,000.00 
$850,000.00 
$0.00 
Equity 
11
2020-05-01 
$4,600,000.00 
INDEFINITE 
INDEFINITE 
Equity 
10
2018-04-10 
$1,800,000.00 
$1,800,000.00 
$0.00 
Equity 
9
2017-11-08 
$6,676,209.00 
$6,676,209.00 
$0.00 
Equity 
8
2017-05-10 
$1,302,292.00 
$3,000,000.00 
$1,697,708.00 
Equity 
7
2016-06-30 
$4,666,666.00 
$4,666,666.00 
$0.00 
Equity 
6
2013-09-30 
$9,900,000.00 
$9,900,000.00 
$0.00 
Equity, Debt 
5
2012-07-31 
$2,538,185.00 
$2,538,185.00 
$0.00 
Equity 
4
2012-06-05 
$5,798,001.00 
$5,798,001.00 
$0.00 
Equity 
3
2012-03-23 
$11,237,011.00 
$11,237,011.00 
$0.00 
Equity, Debt 
2
2010-07-30 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity, Debt 
1
2009-12-30 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
BOHUNICKY 
EXECUTIVE OFFICER
ALAN 
 
DUNTON 
DIRECTOR
JEFFREY 
 
HILLMAN 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
BRIAN 
HIRSCH 
EXECUTIVE OFFICER, DIRECTOR
JANET 
 
HUFFMAN 
EXECUTIVE OFFICER
ALAN 
 
JOSLYN 
EXECUTIVE OFFICER, DIRECTOR
CHRISTINE 
 
KOSKI 
DIRECTOR
ROBERT 
 
KOSKI 
DIRECTOR
KIMBERLY 
 
MURPHY 
EXECUTIVE OFFICER, DIRECTOR
CHARLES 
 
POPE 
DIRECTOR
CHARLES 
L. 
POPE 
DIRECTOR
MICHAEL 
 
SULLIVAN 
EXECUTIVE OFFICER
KIPTRONIC INC.   |  ALLIED IRISH BANKS NORTH AMERICA INC   |  ALLIED IRISH BANKS PLC   |  FLAG INTERNATIONAL PARTNERS II LP   |  FLAG INTERNATIONAL PARTNERS (OFFSHORE) II LP   |  FLAG PRIVATE EQUITY (OFFSHORE) IV LP   |  FLAG PRIVATE EQUITY IV LP   |  FLAG VENTURE PARTNERS VII, L.P.   |  FLAG VENTURE PARTNERS (OFFSHORE) VII, L.P.   |  FREEMAN SULLIVAN CONSULTING INC   |  ARTORIUS PARTNERS II LP   |  EIQNETWORKS INC   |  AFFINE SYSTEMS INC   |  52 WEST 13TH STREET HOLDING LLC   |  RMBS STRATEGIC RECOVERY I OFFSHORE, LP   |  RMBS STRATEGIC RECOVERY I, LP   |  NORTHWOOD REAL ESTATE REIT INC.   |  ARTORIUS PARTNERS II, L.P.   |  GEMINI OPPORTUNITY FUND IV, LLC   |  ORAGENICS INC   |  SNL FINANCIAL LC   |  NORTHWOOD RAVIN LLC   |  HOMELAND HOLDCO, INC.   |  PING IDENTITY CORP   |  APIPHANY, LLC   |  NW FRESHFIELDS REIT LLC   |  NW 100 BROADWAY LLC   |  TERASCALA INC   |  LOTAME SOLUTIONS INC   |  NW COLORADO REIT LLC   |  NW PROSPECT HILL REIT LLC   |  NW 230 CONGRESS STREET REIT LLC   |  NWWP REIT LLC   |  NW 200 SMITH STREET REIT LLC   |  LCP TAMPA INVESTORS, LLC   |  ACHILLES MANAGEMENT LLC   |  LINCHRIS CAPITAL OPPORTUNITY FUND-A, LP   |  LINCHRIS CAPITAL OPPORTUNITY REIT FUND, LP   |  DOUBLEBLUE ARGENTINA CONSUMER FINANCE OFFSHORE FUND I L.P.   |  DOUBLEBLUE ARGENTINA CONSUMER FINANCE FUND I L.P.   |  EHP JACKSONVILLE, LLC   |  HARBORONE BANCORP, INC.   |  LCP REIT, LLC   |  ARTORIUS PARTNERS, L.P.   |  COLONY DISPLAY HOLDINGS LLC   |  ACK NATURAL LLC   |  GLYPHIC REDACTION SOFTWARE, INC.   |  LINCHRIS SPECIAL OPPORTUNITY FUND III, L.P.   |  MB HI OWNER, LLC   |  EVEN KEEL, INC.   |  LSO III REIT, LLC   |  ONEDIGITAL TOPCO LLC
FREDERICK 
 
TELLING 
DIRECTOR
FREDERICK 
W. 
TELLING 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2023-08-04 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2020-05-01 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2018-04-10 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2017-11-08 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2017-05-10 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2016-06-30 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity, Debt 
2013-09-30 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2012-07-31 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2012-07-31 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2012-06-05 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity, Debt 
2012-03-23 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity, Debt 
2010-07-30 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2009-12-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LADENBURG THALMANN + CO. INC.
505
NONE
NONE
GRIFFIN SECURITIES, INC.